Clinical trial Recruiting at 3 sites Phase2; Phase3 Interventional Ages 18 to 65

Enhanced hydrogel xenograft for open maxillary sinus augmentation

Official title: Clinical, Radiographic and Histologic Assessment of a New Xenograft Enhanced With Hydrogel in Augmentation of the Maxillary Sinus: A Randomized Controlled Trial

Run by Misr International University · NCT07737704 · Data updated 2026-11-12

This study tests a hydrogel-enhanced xenograft material to lift the sinus floor during open augmentation and sees if it improves bone formation and tissue response compared with doing the augmentation without graft material.

Quick facts

PhasePhase2; Phase3
Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment30 (estimated)
SponsorMisr International University
Academic / other
Drugs / interventionschemotherapy
Locations3 sites (Ismailia, Ismailia Governorate and 2 other locations)
StatusRecruiting
StartedAugust 10, 2026
Main results expectedJune 10, 2027
Study endsDecember 12, 2027
Registry record updatedJuly 30, 2026
Trial IDNCT07737704 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 and older with at least one missing tooth in the atrophic posterior maxilla and an alveolar height of less than 5 mm requiring open sinus elevation.

Probably not a fit

Patients with uncontrolled medical conditions, active sinus infection, heavy smoking, or contraindications to implant-supported restorations may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, interventional study compares a hydrogel-enhanced xenograft to a graftless approach for lateral maxillary sinus floor elevation in adults with severe posterior maxillary atrophy. Participants undergo sinus elevation with either the xenograft or a graftless method, followed by monitoring of swelling and pain and radiographic evaluation of newly formed bone before implant placement. Outcomes include soft tissue reaction, quantity and quality of formed bone, and radiographic changes over a staged augmentation process. The null hypothesis is that there is no difference between the two methods in tissue response and bone formation. Thirty sites will be studied at two Suez Canal University locations under Misr International University sponsorship.

Why it matters

Potential benefit: If successful, the hydrogel-enhanced xenograft could provide better bone formation and softer tissue response, potentially improving implant success in atrophic posterior maxilla.

How similar studies have gone: Previous approaches to maxillary sinus augmentation have explored graft materials and graftless methods; this study presents a novel hydrogel-enhanced xenograft approach whose comparative performance remains to be established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult male/female patients above the age of 18.
* Patients with one or more teeth requiring implant supported dental restoration in atrophic posterior maxilla.
* Alveolar bone height less than 5 mm at the defective site.
* Good oral hygiene.
* Patient's consensual agreement to be enrolled in the study.

Exclusion Criteria:

* Medically compromised patients with conditions contraindicating surgery (eg. uncontrolled diabetics, bisphosphonate intake, radio or chemotherapy).
* Patients with active infection at or related to the site of surgery (eg. acute sinusitis).
* Heavy smokers.
* Patients not indicated for an implant supported restoration at the time of enrollement.

(Patients developing any medical condition that interferes with the outcomes after enrolment in the study will be excluded).

Where it's running

  • Suez Canal University
    Ismailia, Ismailia Governorate, Egypt
    Recruiting
  • Suez Canal University
    Ismailia, Egypt
    Recruiting
  • Suez Canal University
    Ismailia, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.